Author Interviews, Dermatology / 21.05.2020
FDA Approves Restylane Kysse to Enhance Lips and Decrease Wrinkle Lines
MedicalResearch.com Interview with:
Dr. Melanie D. Palm, MD, MBA
Board-certified dermatologist and cosmetic surgeon
San Diego, CA
Clinical investigator in the Restylane Kysse phase 3 Galaderma trial
Dr. Palm discusses the recent announcement that the FDA has approved Restylane® Kysse for lip augmentation and the correction of upper perioral rhytids (wrinkles) in adults over the age of 21.
MedicalResearch.com: What is the background for this announcement?
-
- Restylane® Kysse has been approved and used in Europe and Canada for several years. It is now the first FDA-approved hyaluronic acid (HA) lip filler in the U.S. formulated with XpresHAn Technology™ (pronounced ex-'spre-shan’) for smooth, natural-looking results.
- It is FDA-approved for use not only in the lip but for improvement of upper lip lines.
- Restylane Kysse is the third product (following Restylane Defyne and Restylane Refyne) in the Restylane family of fillers to use XpresHAn Technology™ which allows for a gel that integrates into the skin for natural expression in motion